World first chronic fatigue syndrome findings could fast track response to Long COVID COVID-19 PublishedAugust 11, 2022September 7, 2022 AuthorEmma O'Connor Study suggests COVID-19 could be a potential trigger for ME/CFS.
World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms Griffith Health PublishedJuly 14, 2021August 17, 2022 AuthorContributed Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.
Researchers discover potential therapeutic approach to treat ME / CFS Griffith Enterprise PublishedNovember 12, 2019November 15, 2019 AuthorCarley Rosengreen Researchers discover drug Naltrexone restored function of faulty receptors associated with ME/CFS.
What is chronic fatigue syndrome? Griffith Health PublishedJanuary 15, 2014January 15, 2014 AuthorContributed Chronic fatigue syndrome, or myalgic encephalomyelitis, is a highly debilitating, but often misunderstood, disorder, writes Professor Sonya Marshall-Gradisnik from the Griffith Health Institute.